%0 Journal Article
%T Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations
%A Xin-Hua Li
%A Yi Lu
%A Yun Ling
%A Qing-Chun Fu
%A Jie Xu
%A Guo-Qing Zang
%A Feng Zhou
%A Yu De-Min
%A Yue Han
%A Dong-Hua Zhang
%A Qi-Ming Gong
%A Zhi-Meng Lu
%A Xiao-Fei Kong
%A Jian-She Wang
%A Xin-Xin Zhang
%J BMC Medical Genetics
%D 2011
%I BioMed Central
%R 10.1186/1471-2350-12-6
%X The coding and promoter regions of the ATP7B gene were analyzed by direct sequencing in 62 Chinese patients (58 probands) with WND (male, n = 37; female, n = 25; age range, 2 ~ 61 years old).Neurologic manifestations were associated with older age at diagnosis (p < 0.0001) and longer diagnostic delay (p < 0.0001). Age at diagnosis was also correlated with urinary copper concentration (r = 0.58, p < 0.001). Forty different mutations, including 14 novel mutations, were identified in these patients. Common mutations included p.Arg778Leu (31.9%) and p.Pro992Leu (11.2%). Homozygous p.Arg778Leu and nonsense mutation/frameshift mutations were more often associated with primary hepatic manifestations (p = 0.0286 and p = 0.0383, respectively) and higher alanine transaminase levels at diagnosis (p = 0.0361 and p = 0.0047, respectively). Nonsense mutation/frameshift mutations were also associated with lower serum ceruloplasmin (p = 0.0065).We identified 14 novel mutations and found that the spectrum of mutations of ATP7B in China is quite distinct from that of Western countries. The mutation type plays a role in predicting clinical manifestations. Genetic testing is a valuable tool to detect WND in young children, especially in patients younger than 8 years old. Four exons (8, 12, 13, and 16) and two mutations (p.Arg778Leu, p.Pro992Leu) should be considered high priority for cost-effective testing in China.Wilson's disease (WND; OMIM#277900) is a rare autosomal recessive disorder that is caused by abnormal copper metabolism; its prevalence is approximately 30 cases per million people [1-4]. The excessive copper accumulation in various organs, primarily the liver, brain, kidney, and cornea, results in a spectrum of hepatic and neurologic abnormalities [5-7]. Clinical presentation is highly heterogeneous [8,9]; patients can present with hepatic symptoms, neurologic symptoms, or both. The age of onset ranges from 2 to 70 years [10-12]. Diagnosis of WND is based on clinical sympto
%U http://www.biomedcentral.com/1471-2350/12/6